55 related articles for article (PubMed ID: 21460362)
21. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.
Johnson SK; Dennis RA; Barone GW; Lamps LW; Haun RS
Mol Carcinog; 2006 Nov; 45(11):814-27. PubMed ID: 16865675
[TBL] [Abstract][Full Text] [Related]
23. Arrangement of expression and distribution of tight junction protein claudin-1 in cell dissociation of pancreatic cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Nakagawa M; Hirota M; Ogawa M
Int J Oncol; 2004 Dec; 25(6):1567-74. PubMed ID: 15547692
[TBL] [Abstract][Full Text] [Related]
24. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Shen Y; Cai M; Xia W; Liu J; Zhang Q; Xie H; Wang C; Wang X; Zheng S
Cancer Lett; 2007 Sep; 254(2):288-97. PubMed ID: 17462818
[TBL] [Abstract][Full Text] [Related]
25. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
Lai RX; Yuan SZ; Nakamura T
Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
[TBL] [Abstract][Full Text] [Related]
26. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
29. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.
Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH
Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664
[TBL] [Abstract][Full Text] [Related]
30. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
31. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
32. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
33. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.
Takano S; Yoshitomi H; Togawa A; Sogawa K; Shida T; Kimura F; Shimizu H; Tomonaga T; Nomura F; Miyazaki M
Oncogene; 2008 May; 27(20):2810-22. PubMed ID: 18037960
[TBL] [Abstract][Full Text] [Related]
35. Chymotrypsin in cancer.
SHIMKIN MB; BIERMAN HR
Proc Soc Exp Biol Med; 1949 Jun; 71(2):250-2. PubMed ID: 18134027
[No Abstract] [Full Text] [Related]
36. Pancreatic cancer: Mass spectrometry indicates malignant potential.
Sidaway P
Nat Rev Clin Oncol; 2018 Feb; 15(2):67. PubMed ID: 29231193
[No Abstract] [Full Text] [Related]
37. Examination of chymotrypsin in the ultracentrifuge.
CECIL R
Biochem J; 1948; 43(1):50. PubMed ID: 18889865
[No Abstract] [Full Text] [Related]
38. A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments.
Pérez-Díez I; Andreu Z; Hidalgo MR; Perpiñá-Clérigues C; Fantín L; Fernandez-Serra A; de la Iglesia-Vaya M; Lopez-Guerrero JA; García-García F
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296850
[TBL] [Abstract][Full Text] [Related]
39. Developmental Phenotypic and Transcriptomic Effects of Exposure to Nanomolar Levels of 4-Nonylphenol, Triclosan, and Triclocarban in Zebrafish (
Phillips J; Haimbaugh AS; Akemann C; Shields JN; Wu CC; Meyer DN; Baker BB; Siddiqua Z; Pitts DK; Baker TR
Toxics; 2022 Jan; 10(2):. PubMed ID: 35202241
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of non-invasive serum Cytokeratin 18 detection in gastrointestinal cancer: a meta-analysis.
Huang Y; Yang L; Lin Y; Chang X; Wu H; Chen Y
J Cancer; 2019; 10(20):4814-4823. PubMed ID: 31598152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]